GSE268273

Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases

Whole-study status Not suitable

Dataset does not meet the current suitability threshold.

Whole-study downloads — these do not apply your sample requirements.

Selected cohort requirements

Samples meeting selected requirements: 0 cases / 0 controls

View matching samples

109 case / 0 control samples elsewhere in the study have incomplete or conflicting evidence; they are not included above

Patient pairs verified in indexed sample metadata: 0

A case/control comparison meeting these requirements is not confirmed.

Counts describe samples, not independent patients. Pair verification uses explicit subject identifiers in indexed sample metadata. Zero verified pairs does not establish that the study is unpaired; reported matched-normal design alone is insufficient.

Summary

Growing evidence suggests an increased prevalence of nonalcoholic fatty liver disease (NAFLD) in the context of immune-mediated inflammatory diseases (IMIDs). We aimed to clinically and mechanistically characterize a prospective cohort of IMID-NAFLD patients compared to classic-NAFLD patients.

Overall design

Comparative gene expression analysis of RNA-seq data from freshly frozen liver biopsies of IMID-NAFLD and classic-NAFLD patients.

Source Evidence

4 sources
Source Contribution Status
GEO

Original dataset metadata, sample metadata, source links, and GEO data availability flags.

Sample records
109 GSM samples
Primary source
recount3

Planned trusted source for processed count availability.

No match found
Expression Atlas

Planned source for curated expression experiment links.

No match found
PubMed

Primary GEO citations and related PubMed articles that mention this dataset.

1 linked publication 1 DOI

Primary publication

  1. Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases. JHEP reports : innovation in hepatology, 2024
Available

Metadata Quality Components

Analysis Readiness

Not ready
55% DE readiness

Contrast completeness

10/25 pts

Only one side of the contrast is present; downstream DE needs both groups.

Minimum group size

0/20 pts

Minimum group size cannot be evaluated until a complete contrast exists.

Processed data availability

20/20 pts

Processed data is marked available in the GEO index.

Sample decision clarity

15/15 pts

All samples are assigned to a case or control group.

Blocking warnings

0/10 pts

Critical warnings must be resolved before downstream analysis.

Metadata normalization

10/10 pts

Metadata quality is high enough to support downstream handoff.

Blockers

  • No complete case/control contrast is available.
  • Critical dataset warnings must be resolved.

Next Steps

  • Resolve critical warnings before downstream analysis.

Analysis Preparation Checklist

4/6 ready

Group labels reviewed

Blocked

No complete case/control grouping exists yet.

Review the sample grouping table and assign both case and control groups.

Minimum sample count met

Blocked

At least one group has fewer than 2 samples.

Choose a larger dataset or merge only scientifically valid groups.

Processed counts available

Ready

Processed data availability is marked true in the GEO index.

Verify that downloaded processed files contain usable count or expression identifiers.

Ambiguous samples handled

Ready

No review-needed or unassigned samples are present in the proposed grouping.

Review the grouping table for biologically meaningful differences that the automated checks may not detect.

Exclusion decisions recorded

Ready

No hard-excluded samples were detected by the current rules.

Record any manual exclusions in the downstream analysis notes.

Source traceability preserved

Ready

The dataset and sample accessions can be traced back to GEO.

Keep GEO accessions with exported metadata.

Bioinformatician Review

Bioinformatician review required

Ask a bioinformatician to review grouping, count availability, exclusions, and design before DE.

Analysis readiness has blockers that must be resolved before DE.

Analysis preparation checklist contains blocked items.

No complete case/control or treatment/control contrast is available.

At least one comparison group has fewer than two samples.

Critical dataset warnings are present.

Study design is model-system or unclear and should be reviewed before analysis.

Why This Is Ranked Here

Tumor vs normal
Not suitable Dataset does not meet the current suitability threshold.

Applied Review Decisions

No active review decisions affect this ranking.

Derived Classifications

  • Disease context Fibrosis, inflammatory bowel disease, liver fibrosis, steatohepatitis, steatotic liver disease, type 2 diabetes Disease context came from Normalization rules.
  • Likely case group Liver fibrosis 109 samples
  • Likely control group No control group detected 0 samples

Intent Interpretation

  • Downgrade or exclusion reason Comparison: Unclear study design. Specimen: Tissue. Comparison suitability: 0%. Derived from current-intent ranking reasons.

Ranking Facts

Supporting evidence

  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Fibrosis, Inflammatory bowel disease, Liver fibrosis, Metabolic disease, Steatohepatitis (NASH/MASH), Steatotic liver disease (NAFLD/MASLD), Type 2 diabetes.
  • Processed data is available for downstream review.
  • External evidence: PubMed links 1 publication; 1 DOI available: PMID 39411649.
  • Publication context: Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases.. JHEP reports : innovation in hepatology, 2024. PMID 39411649. DOI 10.1016/j.jhepr.2024.101167.

Cautions

  • Comparison: Unclear study design. Specimen: Tissue. Comparison suitability: 0%.
  • Downgraded for tissue search because study design or specimen source is unclear.
  • Unclear study design downgraded for patient tissue tumor-vs-normal search intent.
  • Missing or unclear metadata. Unclear study design downgraded for patient tissue tumor-vs-normal search intent.
  • Overall score capped because comparison suitability is weak for the selected search intent.
  • Missing or unclear metadata. Comparison - Unclear study design. Specimen - Tissue. Comparison suitability: 0%.
  • Missing or unclear metadata. Downgraded for tissue search because study design or specimen source is unclear.
  • Comparison suitability score is below the Phase 1 recommended threshold.

Dataset Warnings

Normalized Fields

showing 500 of 671 fields

Sample Group Preview

showing 50 of 109 preview rows
Show Hide
Study totals: Case 109 | Control 0 | Unassigned 0 | Excluded 0 | Ambiguous 0 showing 50 of 109 preview rows
Group Role Accession Title Source / characteristics Reason
Liver fibrosis Case GSM8288976 Sample 1 Liver Tissue: Liver; Sex: Male; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F4; Obesity: Yes; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 110; Hba1c: 5.8; Total cholesterol: 154; Hdl-cholesterol: 40; Ldl-cholesterol: 73; Tryglicerides: 206 Case marker detected.
Liver fibrosis Case GSM8288977 Sample 2 Liver Tissue: Liver; Sex: Male; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F1; Obesity: Yes; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 99; Hba1c: 6.9; Total cholesterol: 147; Hdl-cholesterol: 37; Ldl-cholesterol: 92; Tryglicerides: 93 Case marker detected.
Liver fibrosis Case GSM8288978 Sample 3 Liver Tissue: Liver; Sex: Male; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F1; Obesity: Yes; t2d/ir: No; Hypertension: No; Fasting glycemia: 91; Hba1c: 5.6; Total cholesterol: 141; Hdl-cholesterol: 36; Ldl-cholesterol: 92; Tryglicerides: 66 Case marker detected.
Liver fibrosis Case GSM8288979 Sample 4 Liver Tissue: Liver; Sex: Male; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F2; Obesity: Yes; t2d/ir: No; Hypertension: No; Fasting glycemia: 98; Hba1c: 5.4; Total cholesterol: 310; Hdl-cholesterol: 46; Ldl-cholesterol: 219; Tryglicerides: 226 Case marker detected.
Liver fibrosis Case GSM8288980 Sample 5 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F3; Obesity: Yes; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 157; Hba1c: 8.2; Total cholesterol: 157; Hdl-cholesterol: 40; Ldl-cholesterol: 85; Tryglicerides: 161 Case marker detected.
Inflammatory bowel disease Case GSM8288981 Sample 6 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F1; Obesity: No; t2d/ir: Yes; Hypertension: No; Fasting glycemia: 262; Hba1c: 6.3; Total cholesterol: 234; Hdl-cholesterol: 49; Ldl-cholesterol: 156; Tryglicerides: 145 Case marker detected.
Inflammatory bowel disease Case GSM8288982 Sample 7 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F2; Obesity: Yes; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 69; Hba1c: 5.4; Total cholesterol: 195; Hdl-cholesterol: 52; Ldl-cholesterol: 115; Tryglicerides: 138 Case marker detected.
Fibrosis Case GSM8288983 Sample 8 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & Psoriasis; Fibrosis degree: F3; Obesity: No; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 144; Hba1c: 7.8; Total cholesterol: 154; Hdl-cholesterol: 53; Ldl-cholesterol: 101; Tryglicerides: 259 Case marker detected.
Fibrosis Case GSM8288984 Sample 9 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & Hidradenitis; Fibrosis degree: F0; Obesity: Yes; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 50; Hba1c: 5; Total cholesterol: 211; Hdl-cholesterol: 49; Ldl-cholesterol: 126; Tryglicerides: 179 Case marker detected.
Fibrosis Case GSM8288985 Sample 10 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & Psoriasis; Fibrosis degree: F0; Obesity: Yes; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 129; Hba1c: 5.6; Total cholesterol: 144; Hdl-cholesterol: 35; Ldl-cholesterol: 44; Tryglicerides: 327 Case marker detected.
Fibrosis Case GSM8288986 Sample 11 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & Hidradenitis; Fibrosis degree: F3; Obesity: Yes; t2d/ir: No; Hypertension: No; Fasting glycemia: 82; Hba1c: 5.7; Total cholesterol: 243; Hdl-cholesterol: 61; Ldl-cholesterol: 154; Tryglicerides: 139 Case marker detected.
Inflammatory bowel disease Case GSM8288987 Sample 12 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F1; Obesity: Yes; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 88; Hba1c: 4.8; Total cholesterol: 174; Hdl-cholesterol: 52; Ldl-cholesterol: 84; Tryglicerides: 189 Case marker detected.
Inflammatory bowel disease Case GSM8288988 Sample 13 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F0; Obesity: No; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 84; Hba1c: 4.7; Total cholesterol: 188; Hdl-cholesterol: 57; Ldl-cholesterol: 118; Tryglicerides: 66 Case marker detected.
Inflammatory bowel disease Case GSM8288989 Sample 14 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F0; Obesity: Yes; t2d/ir: No; Hypertension: No; Fasting glycemia: 75; Hba1c: 4.7; Total cholesterol: 269; Hdl-cholesterol: 82; Ldl-cholesterol: 172; Tryglicerides: 73 Case marker detected.
Inflammatory bowel disease Case GSM8288990 Sample 15 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F0; Obesity: No; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 88; Hba1c: 5.4; Total cholesterol: 183; Hdl-cholesterol: 60; Ldl-cholesterol: 102; Tryglicerides: 105 Case marker detected.
Liver fibrosis Case GSM8288991 Sample 16 Liver Tissue: Liver; Sex: Male; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F0; Obesity: Yes; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 143; Hba1c: 5.5; Total cholesterol: 161; Hdl-cholesterol: 53; Ldl-cholesterol: 79; Tryglicerides: 144 Case marker detected.
Liver fibrosis Case GSM8288992 Sample 17 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F1; Obesity: Yes; t2d/ir: Yes; Hypertension: No; Fasting glycemia: 109; Hba1c: 6.1; Total cholesterol: 163; Hdl-cholesterol: 43; Ldl-cholesterol: 96; Tryglicerides: 122 Case marker detected.
Inflammatory bowel disease Case GSM8288993 Sample 18 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F4; Obesity: No; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 119; Hba1c: 7.3; Total cholesterol: 135; Hdl-cholesterol: 44; Ldl-cholesterol: 48; Tryglicerides: 214 Case marker detected.
Inflammatory bowel disease Case GSM8288994 Sample 19 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F1; Obesity: No; t2d/ir: No; Hypertension: No; Fasting glycemia: 72; Hba1c: 5.3; Total cholesterol: 195; Hdl-cholesterol: 57; Ldl-cholesterol: 123; Tryglicerides: 76 Case marker detected.
Liver fibrosis Case GSM8288995 Sample 20 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F2; Obesity: Yes; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 80; Hba1c: 6.3; Total cholesterol: 147; Hdl-cholesterol: 41; Ldl-cholesterol: 77; Tryglicerides: 145 Case marker detected.
Liver fibrosis Case GSM8288996 Sample 21 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F1; Obesity: Yes; t2d/ir: Yes; Hypertension: No; Fasting glycemia: 123; Hba1c: 6; Total cholesterol: 158; Hdl-cholesterol: 36; Ldl-cholesterol: 81; Tryglicerides: 205 Case marker detected.
Inflammatory bowel disease Case GSM8288997 Sample 22 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F0; Obesity: No; t2d/ir: No; Hypertension: No; Fasting glycemia: 75; Hba1c: 5.5; Total cholesterol: 204; Hdl-cholesterol: 44; Ldl-cholesterol: 146; Tryglicerides: 69 Case marker detected.
Fibrosis Case GSM8288998 Sample 23 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & Hidradenitis; Fibrosis degree: F2; Obesity: Yes; t2d/ir: Yes; Hypertension: No; Fasting glycemia: 124; Hba1c: 6.9; Total cholesterol: 150; Hdl-cholesterol: 51; Ldl-cholesterol: 79; Tryglicerides: 98 Case marker detected.
Inflammatory bowel disease Case GSM8288999 Sample 24 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F0; Obesity: Yes; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 119; Hba1c: 5.4; Total cholesterol: 227; Hdl-cholesterol: 59; Ldl-cholesterol: 109; Tryglicerides: 59 Case marker detected.
Liver fibrosis Case GSM8289000 Sample 25 Liver Tissue: Liver; Sex: Male; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F1; Obesity: Yes; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 69; Hba1c: 5; Total cholesterol: 182; Hdl-cholesterol: 35; Ldl-cholesterol: 104; Tryglicerides: 214 Case marker detected.
Liver fibrosis Case GSM8289001 Sample 26 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F0; Obesity: Yes; t2d/ir: No; Hypertension: No; Fasting glycemia: 86; Hba1c: 5.9; Total cholesterol: 197; Hdl-cholesterol: 45; Ldl-cholesterol: 135; Tryglicerides: 86 Case marker detected.
Fibrosis Case GSM8289002 Sample 27 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & Psoriasis; Fibrosis degree: F3; Obesity: Yes; t2d/ir: Yes; Hypertension: No; Fasting glycemia: 106; Hba1c: 7.4; Total cholesterol: 193; Hdl-cholesterol: 33; Ldl-cholesterol: 105; Tryglicerides: 63 Case marker detected.
Liver fibrosis Case GSM8289003 Sample 28 Liver Tissue: Liver; Sex: Male; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F2; Obesity: Yes; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 71; Hba1c: 5.3; Total cholesterol: 266; Hdl-cholesterol: 42; Ldl-cholesterol: 168; Tryglicerides: 282 Case marker detected.
Liver fibrosis Case GSM8289004 Sample 29 Liver Tissue: Liver; Sex: Male; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F0; Obesity: Yes; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 248; Hba1c: 7.5; Total cholesterol: 187; Hdl-cholesterol: 64; Ldl-cholesterol: 103; Tryglicerides: 99 Case marker detected.
Liver fibrosis Case GSM8289005 Sample 30 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F1; Obesity: Yes; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 155; Hba1c: 8.7; Total cholesterol: 220; Hdl-cholesterol: 42; Ldl-cholesterol: 146; Tryglicerides: 158 Case marker detected.
Inflammatory bowel disease Case GSM8289006 Sample 31 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F1; Obesity: Yes; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 82; Hba1c: 5.8; Total cholesterol: 153; Hdl-cholesterol: 31; Ldl-cholesterol: 86; Tryglicerides: 180 Case marker detected.
Inflammatory bowel disease Case GSM8289007 Sample 32 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F0; Obesity: Yes; t2d/ir: No; Hypertension: No; Fasting glycemia: 92; Hba1c: 5.7; Total cholesterol: 257; Hdl-cholesterol: 54; Ldl-cholesterol: 165; Tryglicerides: 188 Case marker detected.
Fibrosis Case GSM8289008 Sample 33 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & Hidradenitis; Fibrosis degree: F4; Obesity: No; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 109; Hba1c: 5.5; Total cholesterol: 163; Hdl-cholesterol: 43; Ldl-cholesterol: 96; Tryglicerides: 122 Case marker detected.
Liver fibrosis Case GSM8289009 Sample 34 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F1; Obesity: Yes; t2d/ir: No; Hypertension: No; Fasting glycemia: 84; Hba1c: 5.8; Total cholesterol: 200; Hdl-cholesterol: 47; Ldl-cholesterol: 130; Tryglicerides: 117 Case marker detected.
Liver fibrosis Case GSM8289010 Sample 35 Liver Tissue: Liver; Sex: Male; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F0; Obesity: No; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 86; Hba1c: 4.7; Total cholesterol: 161; Hdl-cholesterol: 41; Ldl-cholesterol: 96; Tryglicerides: 122 Case marker detected.
Liver fibrosis Case GSM8289011 Sample 36 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F2; Obesity: No; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 105; Hba1c: 5.3; Total cholesterol: 172; Hdl-cholesterol: 47; Ldl-cholesterol: 108; Tryglicerides: 83 Case marker detected.
Inflammatory bowel disease Case GSM8289012 Sample 37 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F3; Obesity: No; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 82; Hba1c: 7.1; Total cholesterol: 205; Hdl-cholesterol: 42; Ldl-cholesterol: 141; Tryglicerides: 111 Case marker detected.
Fibrosis Case GSM8289013 Sample 38 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & Spondylitis; Fibrosis degree: F1; Obesity: Yes; t2d/ir: No; Hypertension: No; Fasting glycemia: 83; Hba1c: 5.9; Total cholesterol: 184; Hdl-cholesterol: 55; Ldl-cholesterol: 99; Tryglicerides: 150 Case marker detected.
Liver fibrosis Case GSM8289014 Sample 39 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F4; Obesity: Yes; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 92; Hba1c: 5.3; Total cholesterol: 148; Hdl-cholesterol: 38; Ldl-cholesterol: 77; Tryglicerides: 221 Case marker detected.
Liver fibrosis Case GSM8289015 Sample 40 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F1; Obesity: Yes; t2d/ir: Yes; Hypertension: No; Fasting glycemia: 94; Hba1c: 4.1; Total cholesterol: 173; Hdl-cholesterol: 56; Ldl-cholesterol: 100; Tryglicerides: 85 Case marker detected.
Liver fibrosis Case GSM8289016 Sample 41 Liver Tissue: Liver; Sex: Male; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F3; Obesity: Yes; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 150; Hba1c: 5.8; Total cholesterol: 208; Hdl-cholesterol: 63; Ldl-cholesterol: 130; Tryglicerides: 76 Case marker detected.
Liver fibrosis Case GSM8289017 Sample 42 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F0; Obesity: Yes; t2d/ir: No; Hypertension: Yes; Fasting glycemia: 92; Hba1c: 6.4; Total cholesterol: 164; Hdl-cholesterol: 31; Ldl-cholesterol: 109; Tryglicerides: 120 Case marker detected.
Liver fibrosis Case GSM8289018 Sample 43 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F3; Obesity: No; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 132; Hba1c: 6.3; Total cholesterol: 185; Hdl-cholesterol: 56; Ldl-cholesterol: 106; Tryglicerides: 116 Case marker detected.
Inflammatory bowel disease Case GSM8289019 Sample 44 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F1; Obesity: Yes; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 97; Hba1c: 6.9; Total cholesterol: 163; Hdl-cholesterol: 42; Ldl-cholesterol: 93; Tryglicerides: 142 Case marker detected.
Fibrosis Case GSM8289020 Sample 45 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & Hidradenitis; Fibrosis degree: F1; Obesity: Yes; t2d/ir: Yes; Hypertension: No; Fasting glycemia: 126; Hba1c: 5.2; Total cholesterol: 196; Hdl-cholesterol: 40; Ldl-cholesterol: 113; Tryglicerides: 215 Case marker detected.
Inflammatory bowel disease Case GSM8289021 Sample 46 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F1; Obesity: No; t2d/ir: Yes; Hypertension: Yes; Fasting glycemia: 185; Hba1c: 8; Total cholesterol: 100; Hdl-cholesterol: 52; Ldl-cholesterol: 22; Tryglicerides: 130 Case marker detected.
Inflammatory bowel disease Case GSM8289022 Sample 47 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F0; Obesity: No; t2d/ir: No; Hypertension: No; Fasting glycemia: 91; Hba1c: 4.7; Total cholesterol: 154; Hdl-cholesterol: 40; Ldl-cholesterol: 55; Tryglicerides: 207 Case marker detected.
Fibrosis Case GSM8289023 Sample 48 Liver Tissue: Liver; Sex: Female; Case/control: IMID-NAFLD; Disease: NAFLD & Spondylitis; Fibrosis degree: F0; Obesity: Yes; t2d/ir: Yes; Hypertension: No; Fasting glycemia: 77; Hba1c: 6.4; Total cholesterol: 160; Hdl-cholesterol: 48; Ldl-cholesterol: 84; Tryglicerides: 141 Case marker detected.
Liver fibrosis Case GSM8289024 Sample 49 Liver Tissue: Liver; Sex: Female; Case/control: Classic-NAFLD; Disease: NAFLD/NASH; Fibrosis degree: F2; Obesity: Yes; t2d/ir: Yes; Hypertension: No; Fasting glycemia: 106; Hba1c: 6.7; Total cholesterol: 181; Hdl-cholesterol: 59; Ldl-cholesterol: 82; Tryglicerides: 199 Case marker detected.
Inflammatory bowel disease Case GSM8289025 Sample 50 Liver Tissue: Liver; Sex: Male; Case/control: IMID-NAFLD; Disease: NAFLD & IBD; Fibrosis degree: F0; Obesity: Yes; t2d/ir: No; Hypertension: No; Fasting glycemia: 81; Hba1c: 5.4; Total cholesterol: 170; Hdl-cholesterol: 62; Ldl-cholesterol: 86; Tryglicerides: 112 Case marker detected.
59 additional case samples are hidden from this preview.

Use as Discovery Cohort

External Validation Finder

Carry Siftome's disease, organism, specimen, assay, data type, and accession into a validation project. Uncertain fields remain Unknown.